Inactivation of IR‐β suppresses SREBP1c expression, downregulating monounsaturated fatty acid levels within HCC cells, making them sensitive to ferritin deposition, thereby inhibiting the tumorigenesis and progression of primary HCC and subcutaneous HCC xenografts [103]. This evidence concerns the gene SREBF1 and hepatocellular carcinoma.